A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

By Roy W. Beck, P. Moke, A. Turpin, F. L. Ferris, J. Sangiovanni, Chris A. Johnson, E. Birch, D. Chandler, T. A. Cox, R. Blair and 1 more. American journal of ophthalmology-glaucoma, 2003

592 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Ophthalmology

View Paper: https://www.semanticscholar.org/paper/9f3dd877020a3c830c4d09d0fefef64d6ce15444

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Ophthalmology

1. Emily Y. Chew
2. J. Sangiovanni

Citations in the corpus

• Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema (2010, background): “The median number of study drug injections before the 1-year primary outcome visit was 8 (6, 10) ranibizumab injections (of 13 maximally possible injections) in the ranibizumab prompt laser group, 9 (6, 11) ranibizumab injections (of 13 maximally possible injections) in the ranibizumab deferred lase”
• Function in the Human Connectome: Task-fMRI and Individual Differences in Behavior (2013, methodology): “The HCP is assessing three different components of visual processing, using; 1) the Electronic Visual Acuity (EVA) system running the Electronic Early Treatment of Diabetic Retinopathy (E-ETDR) protocol (Beck et al., 2003; Moke et al., 2001) to assess visual acuity; 2) the Farnsworth Test to assess ”
• A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion (2009, unknown): “4) 9 (1-17) 31 (19-43) 26 (14-38) 48 31 26”
• Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial (2015, unknown): “Duration of diabetes, median (IQR), y 18 (12-24) 17 (11-23)”
• Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT) (2008, methodology): “1 logMAR found in highly trained normal subjects [2], and also complies with [16] who assessed the reproducibility of FrACT in diabetic patients and [7] who presented an ETDRS-inspired computerized test.”
• Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. (2013, methodology): “At each study visit, participants received a comprehensive eye examination, including best-corrected visual acuity using a standardized protocol.(19) Certified photographers obtained stereoscopic fundus photographs of the macula and optic nerve.”